α-Defensins in the prevention of HIV transmission among breastfed infants

Journal of Acquired Immune Deficiency Syndromes

Volumn 39, Issue 2, 2005, Pages 138-142

  Kuhn, Louise ^a,g   Trabattoni, Daria ^b   Kankasa, Chipepo ^c   Semrau, Katherine ^d   Kasonde, Prisca ^c   Lissoni, Francesca ^b   Sinkala, Moses ^e   Ghosh, Mrinal ^f   Vwalika, Cheswa ^e   Aldrovandi, Grace M ^f   Thea, Donald M ^d   Clerici, Mario ^b  

^a Columbia University ^*  (United States)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY TEACHING HOSPITAL   (Zambia)

^d BOSTON UNIVERSITY   (United States)

^e Lusaka District Health Management Team   (Zambia)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

Author keywords

Breast milk; Defensins; HIV; Transmission

Indexed keywords

ALPHA DEFENSIN; VIRUS RNA;

ADULT; ARTICLE; BREAST FEEDING; BREAST MILK; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; VIRUS TRANSMISSION;

ADULT; ALPHA-DEFENSINS; BREAST FEEDING; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; DISEASE TRANSMISSION, VERTICAL; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; MILK, HUMAN; MULTIVARIATE ANALYSIS; RNA, VIRAL; ZAMBIA;

EID: 21144453694     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Kuhn L, Meddows-Taylor S, Gray G, et al. Human immunodeficiency virus (HIV)-specific cellular immune responses in newboms exposed to HIV in utero. Clin Infect Dis. 2002;34:267-276.
2. Farquhar C, Van Cott TC, Mbori-Ngacha DA, et al. Salivary secretory leukocyte protease inhibitor is associated with reduced transmission of human immunodeficiency virus type 1 through breast milk. J Infect Dis. 2002;186:1173-1176.
3. Mazzoli S, Trabattoni D, Lo Caputo S, et al. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals. Nat Med. 1997;3:1250-1257.
4. Zhang L, Yu W, He T, et al. Contribution of human alpha-detensin 1, 2, and 3 to the anti-HIV-1 activity of CDS antiviral factor. Science. 2002;298:995-1000.
5. Mackewicz CE, Yuan J, Tran P, et al. alpha-Defensins can have anti-HIV activity but are not CDS cell anti-HIV factors. AIDS. 2003;17(Suppl):F23-F32.
6. Wang W, Owen SM, Rudolph DL, et al. Activity of alpha- and theta-defensins against primary isolates of HIV-1. J Immunol. 2004;173:515-520.
7. Trabattoni D, Lo Caputo S, Maffeis G, et al. Human α-defensin in HIV-exposed but uninfected individuals. J Acquire Immun Defic Syndr. 2004;35:455-463.
8. Armogida SA, Yannaras NM, Melton AL, et al. Identification and quantification of innate immune system mediators in human breast milk. Allergy Asthma Proc. 2004;25:297-304.
9. Thea DM, Vwalika C, Kasonde P, et al. Issues in the design of a clinical trial with a behavioral intervention - the Zambia Exclusive Breast-Feeding Study. Control Clin Trials. 2004;25:353-365.
10. Bottcher MF, Jenmalm MC, Garofalo RP, et al. Cytokines in breast milk from allergic and nonallergic mothers. Pediatr Res. 2000;47:157-162.
11. Goldman AS. The immune system of human milk: antimicrobial, antiinflammatory and immunomodulating properties. Pediatr Infect Dis J. 1993;12:664-671.
12. Pillay K, Coutsoudis A, York D, et al. Cell-free virus in breast milk of HIV-1 seropositive women. J Acquir Immune Defic Syndr. 2000;24:330-336.
13. Rousseau CM, Nduati RW, Richardson BA, et al. Longitudinal analysis of human immunodeficiency virus type 1 RNA in breast milk and of its relationship to infant infection and maternal disease. J Infect Dis. 2003;187:741-747.
14. Rousseau CM, Nduati R, Richardson B, et al. Association of levels of HIV-1-infected breast milk cells and risk of mother-to-child transmission. J Infect Dis. 2004; 190:1880-1888.
15. Dolan MJ, Clerici M, Blatt SP, et al. In vitro T cell function, delayed-type hypersensitivity skin testing, and CD4+ T cell subset phenotyping independently predict survival time in patients infected with human immunodeficiency virus. J Infect Dis. 1995;172:79-87.
16. Van de Perre R Mother-to-child transmission of HIV-1: the "all mucosal" hypothesis as a predominant mechanism of transmission. AIDS. 1999;13:1133-1138.
17. Semba RD, Kumwenda N, Taha TE, et al. Mastitis and immunological factors in breast milk of human immunodeficiency virus-infected women. J Hum Lact. 1999;15:301-306.
18. Becquart P, Gresenguet G, Hocini H. et al. Secretory leukocyte protease inhibitor in colostrum and breast milk is not a major determinant of the protection of early postnatal transmission of HIV. AIDS. 1999;13:2599-2602.
19. Van de Perre P, Simonon A, Hitimana DG, et al. Infective and antiinfective properties of breastmilk from HIV-1 infected women. Lancet. 1993;341:914-918.
20. Becquart P, Hocini H, Levy M, et al. Secretory anti-human immunodeficiency virus (HIV) antibodies in colostrum and breast milk are not a major determinant of the protection of early postnatal transmission of HIV J Infect Dis. 2000;181:532-539.
21. Sabbaj S, Edwards BH, Ghosh MK, et al. Human immunodeficiency virus-specific CD8(+) T cells in human breast milk. J Virol. 2002;76:7365-7373.
22. Braida L, Boniotto M, Pontillo A, et al. A single-nucleotide polymorphism in the human beta-defensin 1 gene is associated with HIV-1 infection in Italian children. AIDS, 2004;18:1598-1600.